BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• PSI Supports Alchemia in the “Ride to Conquer Cancer”

  August 22, 2012

   · 

  1 min read
• Business

  Mesoblast Limited Reports Strong Cash Position to Further Diversify Product Pipeline

  August 22, 2012

   · 

  2 min read
• Drug Development

  Symphogen A/S Publishes Final Rozrolimupab (SYM001) Phase 2 Trial Results in ITP in BLOOD Journal

  August 22, 2012

   · 

  1 min read
• Drug Development

  XOMA Corporation Lands Orphan Drug Status for Eye Disease Treatment

  August 22, 2012

   · 

  4 min read
• Policy

  Ex-Sales Rep: Abbott Laboratories Illegally Promoted Blockbuster TriCor

  August 22, 2012

   · 

  2 min read
• Policy

  Astex Pharmaceuticals Climbs on Expected European Approval

  August 22, 2012

   · 

  1 min read
• Biotech Bay

  Gilead Sciences, Inc. Stops Development of PAH Drug After Missing Study Goal

  August 22, 2012

   · 

  1 min read
• Business

  Telcare Raises $25.5 Million in Financing, Led by Sequoia Capital

  August 22, 2012

   · 

  3 min read
• Business

  Joincare to Build $157 Million Antibiotic Facility

  August 22, 2012

   · 

  1 min read
• Pharm Country

  Caliber Imaging & Diagnostics Releases New Products for Noninvasive, Rapid Imaging of Living Cells

  August 22, 2012

   · 

  4 min read